Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ICS
|
||||
| Former ID |
DIB004891
|
||||
| Drug Name |
ProSavin
|
||||
| Synonyms |
Dopamine synthesis pathway gene therapy (Parkinson's disease), Oxford BioMedica
|
||||
| Indication | Parkinson's disease [ICD9: 332; ICD10:G20] | Phase 1/2 | [524296] | ||
| Company |
Oxford BioMedica plc
|
||||
| Target and Pathway | |||||
| Target(s) | GTP cyclohydrolase I | Target Info | Modulator | [551478] | |
| Aromatic-L-amino-acid decarboxylase | Target Info | Modulator | [551478] | ||
| Tyrosine 3-monooxygenase | Target Info | Modulator | [551478] | ||
| WikiPathways | SIDS Susceptibility Pathways | ||||
| Biogenic Amine Synthesis | |||||
| Tryptophan metabolism | |||||
| Dopaminergic Neurogenesis | |||||
| Metabolism of amino acids and derivatives | |||||
| Dopamine metabolism | |||||
| Parkinsons Disease Pathway | |||||
| Nicotine Activity on Dopaminergic NeuronsWP727:Monoamine Transport | |||||
| Nicotine Activity on Dopaminergic Neurons | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.